Visit our Expo - Redox and Inflammation signaling 2012

Friday January 27th, 2006 (Early morning session)
7h30 – 8h30 : Cell Signaling in health and disease : short communications I
7h30 – 7h40 : Bernd Schmeck (Department of Internal Medicine/Infectious Diseases,
Charité, Universitätsmedizin Berlin, Germany ) :
Listeria monocytogenes induced Rac1-dependent endothelial histone modification and
cytokine release
7h40 – 7h50 : Mayra Solis (Terry Fox Molecular Oncology Group, Lady Davis Institute
McGill University, Montreal Canada) :
Distinct roles of IRF-3 and IRF-7 in the activation of anti-tumor properties of human
macrophages
7h50 – 8h00 : Maria C. Albertini (Istituto di Chimica Biologica A. Fornaini, Universita' di
Urbino, Urbino and Universita' di Roma Tor Vergata, Rome, Italy) :
Mechanisms involved in the anti-apoptotic effect of magnetic fields
8h00 – 8h10 : Michal Hayun (Safdié Institute for AIDS and Immunology Research, Faculty
of Life Sciences, Israel) :
The immunomodulator AS101 induces growth arrest and apoptosis in Multiple Myeloma cells
via the PI3-K/Akt pathway.
8h10 – 8h20 : Livio Mallucci (Cell Signaling Laboratory, Pharmaceutical Sciences Research
Division, King's College London, Franklin Wilkins Building, London, UK) :
PI3K Targeting by the Beta-GBP Cytokine. Mitogenic Input and Therapeutic Response
8h20 – 8h30 : Chantal Schwartz (Laboratoire d’Hémato-Cancérologie Expérimentale, CRP-
Santé, Luxembourg) :
Survey on in vitro cell death induction of multiple myeloma cells upon valproic acid
treatment.
Friday January 27th, 2006 (Morning session)
8h30 - 10h30: Inflammation specific signaling
8h30 – 9h00 : Bharat B. Aggarwal (Cytokine Research Section, The University of Texas M.
D. Anderson Cancer Center, Houston, USA):
Targeting Inflammatory Cell signaling pathway for Prevention and Treatment of cancer
9h00 – 9h30 : Mark Ginsberg (Department of Medicine, University of California San
Diego, La Jolla, CA, USA):
Integrin Signaling in Cancer and Inflammation
9h30 – 10h00 : Young-Joon Surh (National Research Laboratory of Molecular
Carcinogenesis and Chemoprevention, College of Pharmacy, Seoul National University,
South Korea):
Redox-Sensitive Transcription Factors as Prime Targets for Chemoprevention and
Cyoprotection
10h00 – 10h15 : Irfan Rahman (Department of Environmental Medicine, Lung Biology and
Disease Program, University of Rochester Medical Center, Rochester, NY, USA):
- 18 -